Gene Therapy Reverses Hearing Loss in Adults and Children
A groundbreaking clinical trial demonstrates that gene therapy using a modified virus can successfully restore hearing in children and young adults with OTOF-related deafness, showing promising safety and efficacy, especially in children aged five to eight, marking a significant advancement in treating genetic hearing loss.